Abbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.
Abbott reported a stronger-than-expected second quarter, driven by robust sales in its device and diagnostic segments. The company has raised its profit forecast for 2026, reflecting confidence in its performance despite previous market concerns regarding potential impacts from subsidy cuts to the Affordable Care Act.
Abbott Laboratories soared the most in 24 years after raising its 2026 profit guidance following a stronger-than-expected second quarter driven by improved performance across most of its business lines.
Abbott investigates two separate cyber incidents, says no operations affected
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday
Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday
Abbott Laboratories Sales Rise on Diagnostics Growth
Abbott raises 2026 profit forecast on heart device strength